Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Semglee biosimilar insulin glargine approved in E.U. and Australia

March 28, 2018

Sichuan Kelun-Biotech Biopharmaceutical patents thrombopoietin receptor agonists

March 28, 2018

Japan's MHLW grants Sakigake designation to JR-141 for Hunter's syndrome

March 28, 2018

Sujanu combination tablets approved in Japan

March 28, 2018

Japanese approval for Orkedia

March 27, 2018

Sanofi seeks U.S. and E.U. approval for sotagliflozin in type 1 diabetes

March 27, 2018

EMA grants PRIME designation for lumasiran in primary hyperoxaluria type 1

March 27, 2018

Amag submits NDA for bremelanotide for hypoactive sexual desire disorder

March 27, 2018

Male contraceptive 11beta-MNTDC reduces testosterone in healthy male volunteers

March 27, 2018

New indication, new formulation of Signifor LAR approved in Japan

March 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...